Right, the denial question again, but with numbers this time. I have 5 data points over 16 weeks. The pattern is consistent enough that I do not think it is chance, and…
u/karim_restrepo
Contributes reviews on supplier material. Based in Accra.
member · joined 15 Jun 2025
Overview — page 2 of 3
comment on what would you tell week-1 you about fertility in c/glp1women · 156 points · 11 months ago
hormonal contraception interactions are speculative
comment on co-agonism — my 6-week log, condensed into one table in c/cagrilintide · 46 points · 11 months ago
That is net peptide content, not purity. Different number, different meaning.
comment on [Question] New Zealand — has anyone got a straight answer on insulin resistance in c/glp1women · 6 points · 1 year ago
no cycle-tracking data with identifying details
comment on [Discussion] private plan is doing more work than we give it credit for in c/glp1canada · 1 points · 1 year ago
This is correct. Name your province.
comment on [Question] perimenopause — what am I missing here in c/glp1women · 1 points · 1 year ago
I am going to push back on this slightly.
comment on [Question] perimenopause — what am I missing here in c/glp1women · 69 points · 1 year ago
Yeah, insulin resistance is under-researched.
comment on step therapy is the most under-discussed thing in c/labresults in c/insurancefights · 10 points · 1 year ago
Mechanistically the bit that matters is external review. It explains most of the early profile and a decent chunk of the outcome.
comment on step therapy is the most under-discussed thing in c/labresults in c/insurancefights · 12 points · 1 year ago
redact member ids and group numbers from every screenshot
comment on [Discussion] the appeal advice in here is 3 years out of date in c/insurancefights · 95 points · 1 year ago
Not to be pedantic but copay and step therapy are being used interchangeably and they are not interchangeable in real life.
comment on tried denial for 4 weeks. here is what happened. in c/insurancefights · 3 points · 1 year ago
step therapy documentation is the weapon, use it
comment on [Vendor] WXT order #9 — the Netherlands, 17 days, no drama, receipts inside in c/insurancefights · 159 points · 1 year ago
This is the "correlation is mechanism" thing again. You changed three variables at once.
comment on the private plan question that gets asked weekly, answered properly in c/glp1canada · 156 points · 1 year ago
Yeah, Denmark coverage is not Denmark coverage.
comment on 7 months in and fertility is still the thing I get wrong in c/glp1women · 78 points · 1 year ago
perimenopause and menopause weight physiology
comment on 14 months in and formulary is still the thing I get wrong in c/insurancefights · 14 points · 1 year ago
external review is the appeal after insurance says no
comment on small win: satiety stopped being a problem at week 25 in c/cagrilintide · 33 points · 1 year ago
amylin receptor distribution is different from GLP-1
comment on [Question] amylin — what am I missing here in c/cagrilintide · 101 points · 2 years ago
The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.
comment on [Meta] the appeal rule is doing its job and people should stop complaining in c/insurancefights · 11 points · 2 years ago
Poland plan: step therapy required 8 medications first. Did them all, got approval. The order matters.
comment on [Meta] the appeal rule is doing its job and people should stop complaining in c/insurancefights · 1 points · 2 years ago
Copay was appeal for the copay then another 7% of the total. Read the actual plan document.
comment on [Meta] the appeal rule is doing its job and people should stop complaining in c/insurancefights · 1 points · 2 years ago
the UK plan: step therapy required 17 medications first. Did them all, got approval. The order matters.